Deadline Approaching! ATS 2022 Respiratory Health Awards
Nominate a colleague who has demonstrated a commitment to respiratory health through their dedicated work and outstanding contributions to the field for one of the ATS 2022 Respiratory Health Awards:
- J. Burns Amberson Lecture
- Edward Livingston Trudeau Medal
- Distinguished Achievement Award
- Jo Rae Wright Award for Outstanding Science
- Outstanding Educator Award
- Public Service Award
- Recognition Awards for Scientific Accomplishments
- Research Innovation and Translation Achievement Award
- World Lung Health Award
- Outstanding Clinician Award
Deadline: Oct. 22, 2021
Nominate a colleague today!
#VaccinesWork
COVID-19 vaccines have arrived, and ATS members know first-hand how important it is for everyone to get vaccinated to protect themselves and the people around them.
Visit us onTwitter to share your perspective on why vaccines work using the hashtag #vaccinesworkand share what you’re seeing at work and in your community.
ATS MECOR India Program: Applications Accepted!
The ATS Methods in Epidemiologic, Clinical, and Operations Research (MECOR) Program is a multi-level research methods training course intended for clinicians, investigators, academicians, and public health professionals who primarily work with pulmonary diseases.
The ATS is now accepting applications for MECOR India, which will take place virtually Feb. 3, 2022 through March 10, 2022.
Deadline to apply: Nov. 1, 2021
Learn more, share widely, and apply!
Upcoming Events
PI-TB Early Career Happy Hour
When: 4 p.m. ET, today, Oct. 13, 2021
Register now.
ATS Clinical Guidelines Webinar
This webinar will highlight what is new or different in three recently published clinical practice guidelines. Full CME available here.
- Home Oxygen Therapy for Children: An Official ATS Clinical Practice Guideline (2019)
- Evaluation and Management of Obesity Hypoventilation Syndrome: An Official ATS Clinical Practice Guideline (2019)
- Home Oxygen Therapy for Adults with Chronic Lung Disease: An Official ATS Clinical Practice Guideline (2020)
When: 5 p.m. ET, Oct. 25, 2021
Register now.
Industry Innovations, “Managing COVID-19 in Hospitalized Patients: Current Treatment Landscape”
Join us for an overview of the current treatment landscape for patients who have been hospitalized with COVID-19 as recommended by the NIH COVID-19 Treatment Guidelines, including remdesivir, dexamethasone, baricitinib, and tocilizumab1. Key data from pivotal clinical trials of these drugs, including time to recovery, mortality, and safety, will be discussed, providing the evidence base for their use in hospitalized COVID-19 patients.
When: 6:30 p.m. ET, Oct. 27, 2021
Register now.
Sponsored by Eli Lilly and Company
EGPA: Facilitating Prompt Recognition and Optimal Treatment
In, "EGPA: Facilitating Prompt Recognition and Optimal Treatment," a one-hour activity led by three EGPA experts, will address the most current information on the diagnosis, treatment initiation, and long-term monitoring of this rare eosinophilic disorder. Full CME information is available here.
Expires: Nov. 13, 2021
Register and get started now!
Supported by an educational grant from GlaxoSmithKline.
Just a Few Weeks Left to Submit Abstracts for ATS 2022!
Join us for the ATS 2022 International Conference in San Francisco! Abstracts can report on basic, translational, and clinical science research; epidemiologic, social, biobehavioral, and psychosocial investigations; or educational and quality improvement projects.
If you would like guidance as you begin the submission process, please see our resources:
- Criteria, Word Count, and Submission Fee
- Instructions for Submitting an Abstract
- List of Scientific Abstract Classifications
- List of Case Report Classifications
View the full submission criteria and ATS 2022 health and safety information.
Deadline: 5 p.m. ET, Nov. 3, 2021
